Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737969 · ClinicalTrials.gov registry record
TEE/Angio Fusion Study
A clinical trial of Structural Heart Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02737969: Completed study of Structural Heart Disease, sponsored by NYU Langone Health.
NCT02737969 is a study of Structural Heart Disease that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737969, a study of Structural Heart Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study of patients undergoing structural heart disease procedures that utilize TEE and fluoroscopic guidance at the New York University (NYU) Langone Medical Center. Patients in this study will undergo their procedure utilizing the TEE/Angio fusion software prototype. This protocol is primarily intended to ascertain the potential utility of the software prototype in the study population and to provide data and feedback to improve the workflow and algorithms of the prototype. As such, a primary outcome variable and statistical analysis plan have not been identified. However, procedural time, measures of radiation exposure (dose area product, total radiation dose, fluoroscopy time), degree of residual valvular regurgitation or paravalvular regurgitation as applicable, and complications will be recorded.
Conditions Studied
Interventions
- DEVICE Transesophageal Echocardiography/angiography (TEE/Angio)
Study Locations (1)
New York
- New York University Langone Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-02 |
What the finished NCT02737969 record still lists
NCT02737969 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Structural Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Transesophageal Echocardiography/angiography (TEE/Angio) is the first listed.
NCT02737969 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02737969 about?
NCT02737969 is a clinical study titled "TEE/Angio Fusion Study". This is a pilot study of patients undergoing structural heart disease procedures that utilize TEE and fluoroscopic guidance at the New York University (NYU) Langone Medical Center. Patients in this study will undergo their procedure utilizing the TEE/Angio fusion software prototype. This protocol is...
What is the current status of trial NCT02737969?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-04. Estimated completion is 2018-05-02.
What conditions does trial NCT02737969 study?
This clinical trial studies the following conditions: Structural Heart Disease.
What interventions are being tested in trial NCT02737969?
The interventions under investigation include: Transesophageal Echocardiography/angiography (TEE/Angio) (DEVICE).
Who is sponsoring clinical trial NCT02737969?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737969 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Structural Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia